The hCG Rapid Test Midstream is a rapid, self-performing, qualitative immunoassay for the determination of human chorionic gonadotropin (hCG) in urine specimen at 20 mIU/ml or above.
Principle of HCG Test Midstream
The hCG Rapid Test Midstream is a qualitative, solid phase, two-site sandwich immunoassay (5-6) for the detection of human chorionic gonadotropin (hCG) in urine. This test utilizes the principle of immuno-chromatography, a unique two-site immunoassay on a membrane. As the test sample flows through the membrane assembly within the test device, the colored anti-hCG-colloidal gold conjugate binds with the hCG in the sample. This complex moves further on the membrane to the test region where it is immobilized by the anti-hCG coated on the membrane leading to formation of a pink colored line which confirms a positive test result. Absence of this colored line in the test region indicates a negative test result.
The unreacted conjugate and unbound complex form a pink line, if any move further on the membrane and are subsequently immobilized by the anti-mouse antibodies coated on the membrane at the control region. This control line serves to validate the test results.
Procedure and Result Reading of HCG Test Midstream
"DIAREAGENT" is governed by Assure Tech. (Hangzhou) Co., Ltd., which is a booming company of biotechnology with strong advantages of specialized talents from research institutes to experienced experts in the field. We dedicate ourselves to the field of diagnostic reagents and biological materials through the operation of R&D, production and sale.
With our research and development programs focusing on rapid diagnosis, small molecule diagnosis, immunological antibody development, micro ... View detail